Cardinal Health, Inc. (NYSE:CAH) Shares Sold by Augustine Asset Management Inc.

Augustine Asset Management Inc. cut its stake in Cardinal Health, Inc. (NYSE:CAH) by 9.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,976 shares of the company’s stock after selling 411 shares during the period. Augustine Asset Management Inc.’s holdings in Cardinal Health were worth $470,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in CAH. Mirae Asset Global Investments Co. Ltd. raised its stake in shares of Cardinal Health by 35.2% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 32,520 shares of the company’s stock valued at $3,871,000 after purchasing an additional 8,471 shares in the last quarter. CHURCHILL MANAGEMENT Corp increased its holdings in Cardinal Health by 1.5% in the fourth quarter. CHURCHILL MANAGEMENT Corp now owns 240,422 shares of the company’s stock valued at $28,435,000 after buying an additional 3,576 shares during the last quarter. Geode Capital Management LLC increased its holdings in Cardinal Health by 0.7% in the third quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company’s stock valued at $633,298,000 after buying an additional 42,082 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in Cardinal Health by 2.3% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,474,625 shares of the company’s stock valued at $162,976,000 after buying an additional 33,388 shares in the last quarter. Finally, Patton Albertson Miller Group LLC bought a new position in Cardinal Health during the 4th quarter worth approximately $258,000. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Price Performance

Shares of Cardinal Health stock opened at $128.38 on Wednesday. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $132.84. The business’s fifty day moving average price is $122.66 and its two-hundred day moving average price is $115.83. The company has a market capitalization of $31.01 billion, a P/E ratio of 23.95, a PEG ratio of 1.49 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. On average, research analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be paid a $0.5056 dividend. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.58%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health’s dividend payout ratio is currently 37.69%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on CAH shares. StockNews.com downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Cardinal Health from $119.00 to $124.00 and gave the company a “hold” rating in a research note on Monday, November 4th. JPMorgan Chase & Co. raised their price target on shares of Cardinal Health from $142.00 to $145.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 4th. Morgan Stanley lifted their price target on shares of Cardinal Health from $136.00 to $142.00 and gave the company an “overweight” rating in a report on Friday, January 31st. Finally, Bank of America upgraded shares of Cardinal Health from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $132.00 to $145.00 in a research note on Monday, January 6th. Four investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat, Cardinal Health has an average rating of “Moderate Buy” and an average price target of $136.87.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.